We believe in the potential
of every human being to
live without limits
Sen-Jam is a catalyst for change.
Sen-Jam innovates to eliminate painful side effects, whether they come from medicine or everyday living.
Life is an adventure, meant to be enjoyed both responsibly and fully. Our goal is to create value by finding novel Pharmaceutical solutions for large, unmet needs while forging global sales, distribution, and licensing agreements with like-minded agents of positive change–companies and innovators that want to make the world a better place. We are currently collaborating with several great partners and welcome conversations to explore possibilities with new ones. Sen-Jam innovates to eliminate many painful side effects. Whether they come from medicine or everyday living. Our product line is based on Opioid Free Pain Relief with GI Protection for Extended Use.
We are passionate about helping people live well, championing happier, healthier, more productive, less pain-filled lives.
We are dedicated to constant improvement, pursuing intellectual and medical curiosity, perpetual learning and innovation.
We are fearlessly reimagining connections, bringing people and organizations together through open communication.
We are relentless about efficacy and safety, supporting only products with clinically proven benefits that outweigh any risk.
Our Leadership Team
Dedicated to ridding the world of side-effects
Jacqueline Iversen, RPh, MS
Jackie has extensive knowledge and capabilities in a multitude of clinical settings. Her expertise involves providing clinical education across the healthcare continuum. She also completed a research fellowship in pharmacokinetics and pain at Memorial Sloan Kettering Cancer Center.
Jim is a Senior Executive with a consistent track record of developing and executing business strategies that deliver rapid growth in sales, profits, market share, employee and customer satisfaction. Client engagements range from start-ups to late stage, often resulting in an M&A transaction.
Thomas Dahl, PhD
Tom has held several senior management positions with companies ranging from start-ups to established global companies. He is an accomplished biotech/pharmaceutical executive with expertise in early stage ventures, including technical analysis of products and technologies, business strategy and operations, development program strategy, clinical trial design and interpretation, and interfacing with pharmaceutical partners.